162 related articles for article (PubMed ID: 29209105)
1. Effects of NSAIDs on the Release of Calcitonin Gene-Related Peptide and Prostaglandin E
Vellani V; Moschetti G; Franchi S; Giacomoni C; Sacerdote P; Amodeo G
Mediators Inflamm; 2017; 2017():9547056. PubMed ID: 29209105
[TBL] [Abstract][Full Text] [Related]
2. Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells.
Neeb L; Hellen P; Hoffmann J; Dirnagl U; Reuter U
J Headache Pain; 2016; 17():19. PubMed ID: 26931452
[TBL] [Abstract][Full Text] [Related]
3. IL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells.
Neeb L; Hellen P; Boehnke C; Hoffmann J; Schuh-Hofer S; Dirnagl U; Reuter U
PLoS One; 2011 Mar; 6(3):e17360. PubMed ID: 21394197
[TBL] [Abstract][Full Text] [Related]
4. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system.
Limmroth V; Katsarava Z; Liedert B; Guehring H; Schmitz K; Diener HC; Michel MC
Pain; 2001 May; 92(1-2):101-6. PubMed ID: 11323131
[TBL] [Abstract][Full Text] [Related]
5. miR-34a-5p up-regulates the IL-1β/COX2/PGE2 inflammation pathway and induces the release of CGRP via inhibition of SIRT1 in rat trigeminal ganglion neurons.
Zhang H; Zhang XM; Zong DD; Ji XY; Jiang H; Zhang FZ; He SD
FEBS Open Bio; 2021 Jan; 11(1):300-311. PubMed ID: 33155431
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones.
Jenkins DW; Feniuk W; Humphrey PP
Br J Pharmacol; 2001 Nov; 134(6):1296-302. PubMed ID: 11704650
[TBL] [Abstract][Full Text] [Related]
7. Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion.
Eftekhari S; Salvatore CA; Calamari A; Kane SA; Tajti J; Edvinsson L
Neuroscience; 2010 Aug; 169(2):683-96. PubMed ID: 20472035
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia.
Raddant AC; Russo AF
Headache; 2014 Mar; 54(3):472-84. PubMed ID: 24512072
[TBL] [Abstract][Full Text] [Related]
9. Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.
Durham PL; Masterson CG
Headache; 2013 Jan; 53(1):67-80. PubMed ID: 23095108
[TBL] [Abstract][Full Text] [Related]
10. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology.
Capuano A; De Corato A; Lisi L; Tringali G; Navarra P; Dello Russo C
Mol Pain; 2009 Aug; 5():43. PubMed ID: 19660121
[TBL] [Abstract][Full Text] [Related]
13. Correlation between algogenic effects of calcitonin-gene-related peptide (CGRP) and activation of trigeminal vascular system, in an in vivo experimental model of nitroglycerin-induced sensitization.
Capuano A; Greco MC; Navarra P; Tringali G
Eur J Pharmacol; 2014 Oct; 740():97-102. PubMed ID: 24998872
[TBL] [Abstract][Full Text] [Related]
14. Repression of stimulated calcitonin gene-related peptide secretion by topiramate.
Durham PL; Niemann C; Cady R
Headache; 2006 Sep; 46(8):1291-5. PubMed ID: 16942474
[TBL] [Abstract][Full Text] [Related]
15. Glyceroltrinitrate facilitates stimulated CGRP release but not gene expression of CGRP or its receptor components in rat trigeminal ganglia.
Eberhardt M; Neeb L; Vogel EM; Tiegs G; Reuter U; Messlinger K; Fischer MJ
Neuropeptides; 2009 Dec; 43(6):483-9. PubMed ID: 19864020
[TBL] [Abstract][Full Text] [Related]
16. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.
Durham PL; Cady R; Cady R
Headache; 2004 Jan; 44(1):35-42; discussion 42-3. PubMed ID: 14979881
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons.
Buldyrev I; Tanner NM; Hsieh HY; Dodd EG; Nguyen LT; Balkowiec A
J Neurochem; 2006 Dec; 99(5):1338-50. PubMed ID: 17064360
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin gene-related peptide (CGRP) and migraine.
Durham PL
Headache; 2006 Jun; 46 Suppl 1(Suppl 1):S3-8. PubMed ID: 16927957
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide inhibits calcitonin gene-related peptide production and release at trigeminal level in the rat.
Greco MC; Capuano A; Navarra P; Tringali G
Eur J Pain; 2016 Jul; 20(6):959-66. PubMed ID: 26729049
[TBL] [Abstract][Full Text] [Related]
20. Role of phosphorylated extracellular signal-regulated kinase, calcitonin gene-related peptide and cyclooxygenase-2 in experimental rat models of migraine.
Dong X; Hu Y; Jing L; Chen J
Mol Med Rep; 2015 Aug; 12(2):1803-9. PubMed ID: 25892078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
